Means and methods for manufacturing highly pure neurotoxin

Details for Australian Patent Application No. 2010214834 (hide)

Owner Merz Pharma GmbH & Co. KGaA

Inventors Pfeil, Michael; Friedrich, Josef; Taylor, Harold V.; Eisele, Karl-Heinz; Brunn, Cornelia

Agent EKM patent & trade marks

Pub. Number AU-A-2010214834

PCT Pub. Number WO2010/094463

Priority 61/275,173 26.08.09 US; 09153226.7 19.02.09 EP; 61/207,989 19.02.09 US; 09168679.0 26.08.09 EP

Filing date 17 February 2010

Wipo publication date 26 August 2010

International Classifications

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 1/22 (1970.01) General processes for the preparation of peptides

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

C07K 16/06 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - from serum

Event Publications

18 August 2011 PCT application entered the National Phase

  PCT publication WO2010/094463 Priority application(s): WO2010/094463

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010214841-Seating furniture, in particular office swivel chair

2010214818-Drive device of a regulation valve for casting liquid metal